What is Kymera Therapeutics's shares (basic)?

Kymera Therapeutics (KYMR) reported shares (basic) of 97.5M in Q1 2026.

How has Kymera Therapeutics's shares (basic) changed year-over-year?

Kymera Therapeutics's shares (basic) increased by 21.7% year-over-year, from 80.1M to 97.5M.

What is the long-term trend for Kymera Therapeutics's shares (basic)?

Over 3 years (2022 to 2025), Kymera Therapeutics's shares (basic) has grown at a 16.2% compound annual growth rate (CAGR), from 211.9M to 332.4M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Kymera Therapeutics KYMR Shares (Basic)

Shares (Basic) at other companies

PfizerPFE

5.7B+0.3%

Johnson & JohnsonJNJ

2.4B+0.1%

Regeneron PharmaceuticalsREGN

104M-2.5%

ImmunityBio, Inc.IBRX

1B+20.4%

Krystal Biotech, Inc.KRYS

29.3M+1.6%

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's shares (basic)?: Kymera Therapeutics (KYMR) reported shares (basic) of 97.5M in Q1 2026.
How has Kymera Therapeutics's shares (basic) changed year-over-year?: Kymera Therapeutics's shares (basic) increased by 21.7% year-over-year, from 80.1M to 97.5M.
What is the long-term trend for Kymera Therapeutics's shares (basic)?: Over 3 years (2022 to 2025), Kymera Therapeutics's shares (basic) has grown at a 16.2% compound annual growth rate (CAGR), from 211.9M to 332.4M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.